---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-014013"
form_type: "8-K"
ticker: "FORA"
cik: "0001829280"
company_name: "Forian Inc."
filed_at: "2023-03-27T23:59:59+00:00"
generated_at: "2026-06-17T15:28:13.060279+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Forian Q4 revenue up 37% YoY to $7.9M; divests BioTrack for $30M; guides FY2023 rev $20.5-22.5M

## Summary
- Q4 2022 revenue $7.9M (+37% YoY); net loss $3.6M vs $8.0M; adj. EBITDA -$0.9M vs -$4.5M.
- Full year 2022 revenue $28.0M (+66% YoY); net loss $26.0M vs $26.6M; healthcare info rev grew 130% to $16.4M.
- In February 2023, completed sale of BioTrack for $30M cash, strengthening balance sheet.
- FY2023 guidance: healthcare info rev growth 25-37%, total rev $20.5-22.5M; positive adj. EBITDA expected in H2 2023.
- Cash, equivalents and marketable securities at Dec 31, 2022 were $20.7M, boosted by BioTrack proceeds post-period.

## SEC filing metadata
- accession: 0001140361-23-014013
- form_type: 8-K
- ticker: FORA
- cik: 0001829280
- company_name: Forian Inc.
- filed_at: 2023-03-27T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829280/000114036123014013/0001140361-23-014013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829280/000114036123014013/brhc10050309_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-014013
- JSON: https://secwatch.observer/filing/0001140361-23-014013.json
- Plain text: https://secwatch.observer/filing/0001140361-23-014013.txt

## Key facts
- Earnings Releases
  Forian Inc. reported the three months ended December 31, 2022 results: revenue $ 7,903,992, net income $ (3,556,714 ), EPS $ (0.11 ).
  - Period: the three months ended December 31, 2022
  - Revenue: $ 7,903,992
  - Net income: $ (3,556,714 )
  - EPS: $ (0.11 )
  - Result: reported results
  source text: Forian delivered the following results for the fourth quarter of 2022: Three Months Ended December 31, Period-over- 2022 2021 Period Unaudited Unaudited % Change Total revenues $ 7,903,992 $ 5,749,366 37% Net loss $ (3,556,714 ) $ (8,048,790 ) 56% Basic and diluted net loss per common share $ (0.11 ) $ (0.22 ) 51%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036123014013/0001140361-23-014013-index.htm
- Earnings Releases
  Forian Inc. reported the twelve months ended December 31, 2022 results: revenue $ 28,005,857, net income $ (25,971,971 ), EPS $ (0.81 ).
  - Period: the twelve months ended December 31, 2022
  - Revenue: $ 28,005,857
  - Net income: $ (25,971,971 )
  - EPS: $ (0.81 )
  - Result: reported results
  source text: Forian delivered the following results for the full year of 2022: Twelve Months Ended December 31, Period-over- 2022 2021 Period Unaudited Unaudited % Change Total revenues $ 28,005,857 $ 16,879,715 66% Net loss $ (25,971,971 ) $ (26,551,105 ) 2% Basic and diluted net loss per common share $ (0.81 ) $ (0.90 ) 10%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036123014013/0001140361-23-014013-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.